Marcadia Biotech lands $15M in venture funding
Carmel drug developer Marcadia Biotech has received a $15 million venture capital investment from Frazier Healthcare Ventures of Seattle and locally based Twilight Venture Partners. The funding will help Marcadia develop projects including a glucagon analog for emergency treatment of hypoglycemia, the company announced today. Marcadia, which is led by former senior executives of Eli Lilly […]